Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Smart In-Vitro Diagnostics - Artificial Intelligence for In Vitro Diagnostics Markets by Application, by Technology and by User with Executive and Consultant Guides 2023-2027" report has been added to ResearchAndMarkets.com's offering.
The latest research publication underscoring the transformative impact of Smart In-Vitro Diagnostics (IVD) and Artificial Intelligence (AI) on medical diagnostics has been added to our leading online platform, highlighting significant market dynamics and growth trends for 2023-2027.
The integration of AI in the medical diagnostic field is poised to revolutionize the industry, enhancing the accuracy and speed of disease detection. This groundbreaking research assesses the emerging IVD markets, driven by technological innovation and the increasing demand for efficient diagnostic methods.
Technological Advancements and Market Growth
Smart Diagnostics: A New Era of Clinical Innovation
- The research emphasizes the transition from research-focused Smart Diagnostics to their widespread clinical application.
- It explores the market's current explosive growth, indicating a robust trajectory as multiplex testing begins to supplant other diagnostics methods.
AI-Powered Diagnostics: A Game Changer in Healthcare
- Artificial Intelligence is rapidly garnering attention for its role in augmenting diagnostic processes, particularly in image analysis for radiology and pathology.
- The publication anticipates an accelerated adoption of AI in mainstream In-Vitro Diagnostics, transforming diagnostic accuracy and patient care.
Implications for Medical Practice and Diagnosis
With advancements in genomics and the cost-effective nature of evolving IVD technologies, the report projects a significant influence on healthcare practices. The promise of broad-spectrum blood testing combined with AI presents a potential shift in the paradigm of medical diagnosis, predicted to provide sharper, faster, and more comprehensive disease analysis in the near future.
A Detailed Market Analysis
The examination of the Smart In-Vitro Diagnostics market provides an incisive country-wise breakdown for 18 countries and regional analysis for 4 key regions, assessing the scale and nuances of the global market landscape and identifying the primary movers and growth indicators.
This research stands as a crucial instrument for stakeholders across the healthcare spectrum, from clinical entities planning expansion to laboratories aiming to invest in new testing regimes. The in-depth analysis and forecasts contained within this report are vital for understanding the evolving intersection of In-Vitro Diagnostics and Artificial Intelligence and their collective impact on the future of global medical practice.
Advised by industry experts, the comprehensive publication encapsulates a pivotal moment in healthcare innovation. It is a testament to the leaps taking place within the realm of diagnostics and the burgeoning role AI is set to play in the field of In Vitro Diagnostics.
For more details and access to the report, interested parties are encouraged to visit our website, where the full scope of insights and forecasted trends can be explored.
Key Topics Covered:
- Market Guides
- Strategic Situation Analysis
- Guide for Executives, Marketing, and Business Development Staff
- Guide for Management Consultants and Investment Advisors
- Introduction and Market Definition
- Understanding Smart Diagnostics and Market Definition
- Perspectives on Healthcare and the IVD Industry
- Market Overview
- Players in a Dynamic Market
- Exploring Artificial Intelligence Applications in IVD
- Market Trends
- Drivers and Challenges Shaping Market Growth
- Instrumentation, Automation, and Diagnostic Trends
- Recent Developments
- Innovations Driving Advancements in Smart Diagnostics
- Profiles of Key Players
- Highlighting Key Companies Driving Smart Diagnostics Innovations
- The Global Market for Smart Diagnostics
- Overview by Country, Application, Technology, and Place
- Global Markets - By Application
- Insights into Cancer, Infectious Disease, Metabolic Testing, and More
- Global Markets - By Technology
- NGS, PCR, Chemistry/IA, Pathology Technology, and Other Innovations
- Global Markets - By Place
- Research, Pharmaceutical Research, Clinical, and Other Applications
- Appendices
- In-depth Insights on the United States Medicare System and IVD Assays
Companies Mentioned
- Adaptive Biotechnologies
- Aidoc
- Anumana
- ARUP Laboratories
- Atomwise
- Bayesian Health
- Behold.ai
- BGI Genomics Co. Ltd
- bioMérieux Diagnostics
- Bio-Rad Laboratories, Inc
- Cambridge Cognition
- Cardiologs (Phillips)
- CareDx
- Caris Molecular Diagnostics
- Cleerly
- ClosedLoop AI
- CloudMedX Health
- Deepcell
- Digital Diagnostics
- EKF Diagnostics Holdings
- Freenome
- GE Healthcare
- Glooko
- Idoven
- Illumina
- Infohealth
- Jade
- K Health
- Lunit
- MaxCyte
- Mayo Clinic Laboratories
- Medtronic
- Merative
- Nanox
- NIOX Group
- Niramai Health Analytix
- NVIDIA
- Oncohost
- OraLiva
- Owkin
- Oxford Nanopore Technologies
- Pacific Biosciences
- Paige.AI
- PathAI
- Perthera
- Philips Healthcare
- Prognos
- Qiagen
- Qure.ai
- Renalytix
- Seegene
- Siemens Healthineers
- Sophia Genetics
- Sysmex
- Viz.ai
For more information about this report visit https://www.researchandmarkets.com/r/b309hj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
